Search Ontology:
ChEBI
(2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
- Term ID
- CHEBI:151646
- Synonyms
-
- 2-deoxy-2-sulfoamino-alpha-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronic acid
- GlcNS(a1-4)b-GlcA
- WURCS=2.0/2,2,1/[a2122A-1b_1-5][a2122h-1a_1-5_2*NSO/3=O/3=O]/1-2/a4-b1
- Definition
- References
-
- GlyGen:G52523DM
- GlyTouCan:G52523DM
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from (2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
Phenotype where environments contain (2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
Phenotype modified by environments containing (2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
Human Disease Model